110
Participants
Start Date
July 18, 2022
Primary Completion Date
July 9, 2024
Study Completion Date
July 9, 2024
Silodosin
Silodosin is an α1A-adrenergic receptor antagonist which can relax the smooth muscle of bladder and prostate, relieve the dynamic obstruction of bladder outlet, and improve the lower urinary tract symptoms caused by BPH. The instruction of Silodosin Capsule (Qianweitai®) is 4mg/capsule,1 capsule/time, bid, after breakfast and dinner.
Tamsolusin
Tamsulosin is an α1A-adrenergic receptor blocker which has used in treatment of BPH for few years. The instruction of Tamsulosin Capsule is 1 tablet at a time, 1 time a day.
The First Affiliated Hospital of Anhui Medical University, Hefei
Wuhan Center Hospital, Wuhan
Wuhan No.1 Hospital, Wuhan
The Second Affiliated Hospital of Suzhou University, Suzhou
Beijing Tongren Hospital, Capital Medical University, Beijing
Ciivil Aviation General Hospital, Beijing
Shanghai Huilun Pharmaceutical Co., Ltd.
INDUSTRY